{"id":"https://openalex.org/W4413329945","doi":"https://doi.org/10.3390/curroncol32080471","title":"Treatment Disparities, Heterogeneities, and Barriers to Access for Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A National Survey from Brazil","display_name":"Treatment Disparities, Heterogeneities, and Barriers to Access for Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A National Survey from Brazil","publication_year":2025,"publication_date":"2025-08-19","ids":{"openalex":"https://openalex.org/W4413329945","doi":"https://doi.org/10.3390/curroncol32080471","pmid":"https://pubmed.ncbi.nlm.nih.gov/40862840","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12384988"},"language":"en","primary_location":{"id":"doi:10.3390/curroncol32080471","doi":"https://doi.org/10.3390/curroncol32080471","is_oa":true,"landing_page_url":"https://doi.org/10.3390/curroncol32080471","pdf_url":"https://www.mdpi.com/1718-7729/32/8/471/pdf?version=1755594835","source":{"id":"https://openalex.org/S113449754","display_name":"Current Oncology","issn_l":"1198-0052","issn":["1198-0052","1718-7729"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/1718-7729/32/8/471/pdf?version=1755594835","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054958027","display_name":"Heloisa Magda Resende","orcid":"https://orcid.org/0000-0003-4692-3743","observed_orcids":["https://orcid.org/0000-0003-4692-3743"]},"institutions":[{"id":"https://openalex.org/I4210111468","display_name":"Centro Universit\u00e1rio de Volta Redonda","ror":"https://ror.org/01vn2rt83","country_code":"BR","type":"education","lineage":["https://openalex.org/I4210111468"]}],"countries":["BR"],"is_corresponding":true,"raw_author_name":"Heloisa Resende","raw_affiliation_strings":["Centro Universit\u00e1rio de Volta Redonda (UniFOA), Volta Redonda 27240-560, Rio de Janeiro, Brazil","Instituto Projeto CURA, S\u00e3o Paulo 05507-020, S\u00e3o Paulo, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Universit\u00e1rio de Volta Redonda (UniFOA), Volta Redonda 27240-560, Rio de Janeiro, Brazil","institution_ids":["https://openalex.org/I4210111468"]},{"raw_affiliation_string":"Instituto Projeto CURA, S\u00e3o Paulo 05507-020, S\u00e3o Paulo, Brazil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113415509","display_name":"Vin\u00edcius Aguiar","orcid":"https://orcid.org/0009-0002-8329-5168","observed_orcids":["https://orcid.org/0009-0002-8329-5168"]},"institutions":[{"id":"https://openalex.org/I4210111468","display_name":"Centro Universit\u00e1rio de Volta Redonda","ror":"https://ror.org/01vn2rt83","country_code":"BR","type":"education","lineage":["https://openalex.org/I4210111468"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Vin\u00edcius de Q. Aguiar","raw_affiliation_strings":["Centro Universit\u00e1rio de Volta Redonda (UniFOA), Volta Redonda 27240-560, Rio de Janeiro, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Universit\u00e1rio de Volta Redonda (UniFOA), Volta Redonda 27240-560, Rio de Janeiro, Brazil","institution_ids":["https://openalex.org/I4210111468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107406805","display_name":"Nataline Freitas de Azevedo Santos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111468","display_name":"Centro Universit\u00e1rio de Volta Redonda","ror":"https://ror.org/01vn2rt83","country_code":"BR","type":"education","lineage":["https://openalex.org/I4210111468"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Nataline F. de A. Santos","raw_affiliation_strings":["Centro Universit\u00e1rio de Volta Redonda (UniFOA), Volta Redonda 27240-560, Rio de Janeiro, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Universit\u00e1rio de Volta Redonda (UniFOA), Volta Redonda 27240-560, Rio de Janeiro, Brazil","institution_ids":["https://openalex.org/I4210111468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105961426","display_name":"Jo\u00e3o V\u00edtor Siqueira Jardim","orcid":"https://orcid.org/0009-0006-3329-4991","observed_orcids":["https://orcid.org/0009-0006-3329-4991"]},"institutions":[{"id":"https://openalex.org/I4210111468","display_name":"Centro Universit\u00e1rio de Volta Redonda","ror":"https://ror.org/01vn2rt83","country_code":"BR","type":"education","lineage":["https://openalex.org/I4210111468"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Jo\u00e3o Vitor Siqueira Jardim","raw_affiliation_strings":["Centro Universit\u00e1rio de Volta Redonda (UniFOA), Volta Redonda 27240-560, Rio de Janeiro, Brazil"],"raw_orcid":"https://orcid.org/0009-0006-3329-4991","affiliations":[{"raw_affiliation_string":"Centro Universit\u00e1rio de Volta Redonda (UniFOA), Volta Redonda 27240-560, Rio de Janeiro, Brazil","institution_ids":["https://openalex.org/I4210111468"]}]},{"author_position":"last","author":{"id":null,"display_name":"Andr\u00e9 Ornelas","orcid":"https://orcid.org/0009-0008-3019-2687","observed_orcids":["https://orcid.org/0009-0008-3019-2687"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Andr\u00e9 Ornelas","raw_affiliation_strings":["Novartis Brazil, S\u00e3o Paulo 04706-900, S\u00e3o Paulo, Brazil"],"raw_orcid":"https://orcid.org/0009-0008-3019-2687","affiliations":[{"raw_affiliation_string":"Novartis Brazil, S\u00e3o Paulo 04706-900, S\u00e3o Paulo, Brazil","institution_ids":["https://openalex.org/I1283582996"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5054958027"],"corresponding_institution_ids":["https://openalex.org/I4210111468"],"apc_list":{"value":2200,"currency":"CHF","value_usd":2654},"apc_paid":{"value":2200,"currency":"CHF","value_usd":2654},"fwci":1.122,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.72929873,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":98},"biblio":{"volume":"32","issue":"8","first_page":"471","last_page":"471"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.6577000021934509,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.6577000021934509,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.050700001418590546,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13544","display_name":"Women's cancer prevention and management","score":0.015699999406933784,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9120000004768372},{"id":"https://openalex.org/keywords/hr-her2-breast-cancer","display_name":"hormone receptor-positive HER2-negative breast cancer","score":0.8939999938011169},{"id":"https://openalex.org/keywords/treatment-disparities","display_name":"treatment disparities","score":0.8090000152587891},{"id":"https://openalex.org/keywords/access-to-cancer-care","display_name":"access to cancer care","score":0.7590000033378601},{"id":"https://openalex.org/keywords/waiting-time","display_name":"waiting time","score":0.5899999737739563},{"id":"https://openalex.org/keywords/unified-health-system-sus","display_name":"Unified Health System (SUS)","score":0.8090000152587891},{"id":"https://openalex.org/keywords/private-health-system","display_name":"private health system","score":0.7739999890327454},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.7850000262260437},{"id":"https://openalex.org/keywords/palliative-care","display_name":"palliative care","score":0.8149999976158142},{"id":"https://openalex.org/keywords/multidisciplinary-care","display_name":"multidisciplinary care","score":0.8939999938011169},{"id":"https://openalex.org/keywords/health-system-investment","display_name":"health system investment","score":0.5270000100135803},{"id":"https://openalex.org/keywords/brazil","display_name":"Brazil","score":0.9340000152587891}],"concepts":[{"id":"https://openalex.org/C2908728163","wikidata":"https://www.wikidata.org/wiki/Q415271","display_name":"Human Epidermal Growth Factor Receptor 2","level":4,"score":0.7916232347488403},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7050948143005371},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6178112626075745},{"id":"https://openalex.org/C23589133","wikidata":"https://www.wikidata.org/wiki/Q412005","display_name":"Hormone receptor","level":4,"score":0.5966532826423645},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5516926050186157},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5476741194725037},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5004076957702637},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4718133211135864},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.46187758445739746},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.4550709128379822},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4482937157154083},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.4200393855571747}],"mesh":[{"descriptor_ui":"D001938","descriptor_name":"Brazil","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006297","descriptor_name":"Health Services Accessibility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011960","descriptor_name":"Receptors, Estrogen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D054625","descriptor_name":"Healthcare Disparities","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.3390/curroncol32080471","doi":"https://doi.org/10.3390/curroncol32080471","is_oa":true,"landing_page_url":"https://doi.org/10.3390/curroncol32080471","pdf_url":"https://www.mdpi.com/1718-7729/32/8/471/pdf?version=1755594835","source":{"id":"https://openalex.org/S113449754","display_name":"Current Oncology","issn_l":"1198-0052","issn":["1198-0052","1718-7729"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Oncology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:11192663","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12384988","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:40862840","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40862840","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current oncology (Toronto, Ont.)","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12384988","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12384988/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Curr Oncol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:3b6f8e691e164dc289d69178f63b51e7","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/3b6f8e691e164dc289d69178f63b51e7","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Current Oncology, Vol 32, Iss 8, p 471 (2025)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3390/curroncol32080471","doi":"https://doi.org/10.3390/curroncol32080471","is_oa":true,"landing_page_url":"https://doi.org/10.3390/curroncol32080471","pdf_url":"https://www.mdpi.com/1718-7729/32/8/471/pdf?version=1755594835","source":{"id":"https://openalex.org/S113449754","display_name":"Current Oncology","issn_l":"1198-0052","issn":["1198-0052","1718-7729"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"},{"id":"https://metadata.un.org/sdg/10","score":0.9629999995231628,"display_name":"Reduced inequalities"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4413329945.pdf","grobid_xml":"https://content.openalex.org/works/W4413329945.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W1964925584","https://openalex.org/W2166085636","https://openalex.org/W2404884142","https://openalex.org/W2945418760","https://openalex.org/W2961215481","https://openalex.org/W3033227960","https://openalex.org/W3034619632","https://openalex.org/W3045760658","https://openalex.org/W3128646645","https://openalex.org/W3144004986","https://openalex.org/W3165444333","https://openalex.org/W3188123978","https://openalex.org/W4200621815","https://openalex.org/W4285592919","https://openalex.org/W4309048328","https://openalex.org/W4311090448","https://openalex.org/W4316589278","https://openalex.org/W4366758986","https://openalex.org/W4382465418","https://openalex.org/W4388308554","https://openalex.org/W4406939477","https://openalex.org/W4410433284","https://openalex.org/W4410762706","https://openalex.org/W4411349176","https://openalex.org/W6790598159","https://openalex.org/W6880467086"],"related_works":["https://openalex.org/W4396599358","https://openalex.org/W4410762706","https://openalex.org/W2790737702","https://openalex.org/W4414346967","https://openalex.org/W4407397510","https://openalex.org/W4322774120","https://openalex.org/W4414942965","https://openalex.org/W4403947267","https://openalex.org/W4399118573","https://openalex.org/W3033227960"],"abstract_inverted_index":{"Breast":[0],"cancer":[1],"(BC)":[2],"is":[3],"the":[4,16,30,34,119,131,137,149,161,166,195],"most":[5],"common":[6],"malignancy":[7],"among":[8],"Brazilian":[9],"women,":[10],"with":[11,192],"a":[12,109],"high":[13],"percentage":[14],"of":[15,29,90,111,176,188],"cases":[17],"diagnosed":[18],"at":[19],"advanced":[20],"or":[21],"metastatic":[22],"stages":[23],"(mBC).":[24],"In":[25],"Brazil,":[26],"where":[27],"75%":[28],"population":[31],"depends":[32],"on":[33],"resource-limited":[35],"public":[36,67],"health":[37,70,214],"system":[38,197],"(SUS),":[39],"mBC":[40,65,207],"poses":[41],"significant":[42],"treatment":[43,57,87,164],"challenges":[44],"and":[45,68,93,97,105,116,143],"disparities.":[46],"To":[47],"characterize":[48],"this":[49],"scenario,":[50],"we":[51],"conducted":[52],"an":[53],"online":[54],"survey":[55,74],"assessing":[56],"strategies":[58],"available":[59,172,184],"for":[60,125,144],"HER2-negative,":[61],"hormone":[62],"receptor":[63],"(HR)-positive":[64],"across":[66],"private":[69,138,196],"systems.":[71],"The":[72,122],"48-question":[73],"addressed":[75],"topics":[76],"such":[77],"as":[78],"waiting":[79],"time":[80],"(WT)":[81],"from":[82],"oncology":[83],"unit":[84],"entry":[85],"to":[86,95,173,186],"initiation,":[88],"availability":[89],"oncologic":[91],"medications,":[92],"access":[94],"palliative":[96,180],"multidisciplinary":[98],"care":[99,181],"teams.":[100],"Between":[101],"2":[102],"August":[103],"2022":[104],"30":[106,134,146],"September":[107],"2022,":[108],"total":[110],"180":[112],"oncologists":[113],"were":[114,183],"invited,":[115],"150":[117],"met":[118],"inclusion":[120],"criteria.":[121],"median":[123],"WT":[124],"surgery":[126],"was":[127,160,171],"60":[128],"days":[129,135,147,153],"in":[130,136,148,165,194,206],"SUS":[132,150,167,189],"versus":[133,151],"sector":[139],"(p":[140,155,198],"<":[141,156],"0.0001),":[142],"chemotherapy,":[145],"15":[152],"privately":[154],"0.0001).":[157],"Endocrine":[158],"therapy":[159],"preferred":[162],"first-line":[163],"(83.3%),":[168],"while":[169],"fulvestrant":[170],"only":[174],"48%":[175],"respondents.":[177],"Additionally,":[178],"specialized":[179],"teams":[182],"according":[185],"66%":[187],"respondents":[190],"compared":[191],"82%":[193],"=":[199],"0.001).":[200],"These":[201],"findings":[202],"underscore":[203],"persistent":[204],"disparities":[205],"treatment,":[208],"likely":[209],"driven":[210],"by":[211],"limited":[212],"governmental":[213],"investment.":[215]},"counts_by_year":[{"year":2026,"cited_by_count":4}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2025-10-10T00:00:00"}